These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2398274

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Demonstration of anti-idiotypic antibodies directed against IgM rheumatoid factor in the serum of rheumatoid arthritis patients.
    Hancock WK, Barnett EV.
    Clin Exp Immunol; 1989 Jan; 75(1):25-9. PubMed ID: 2702773
    [Abstract] [Full Text] [Related]

  • 5. Synovial fluid from patients with rheumatoid arthritis contains a unique inhibitor of interleukin 1 alpha.
    Higgins GC, Postlethwaite AE.
    J Rheumatol; 1996 Jun; 23(6):965-73. PubMed ID: 8782124
    [Abstract] [Full Text] [Related]

  • 6. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission.
    Cavill D, Waterman SA, Gordon TP.
    Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012
    [Abstract] [Full Text] [Related]

  • 7. Characterization and detection of naturally occurring antibodies against IL-1 alpha and IL-1 beta in normal human plasma.
    Gallay P, Mach JP, Carrel S.
    Eur Cytokine Netw; 1991 Dec; 2(5):329-38. PubMed ID: 1839507
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E, Horst G, Nijk MT, Limburg PC, Kallenberg CG, Bijl M.
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of interleukin-6 (IL-6) autoantibodies on IL-6 binding to cellular receptors.
    Hansen MB, Svenson M, Abell K, Yasukawa K, Diamant M, Bendtzen K.
    Eur J Immunol; 1995 Feb; 25(2):348-54. PubMed ID: 7875195
    [Abstract] [Full Text] [Related]

  • 13. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M, Kawashima M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Morita Y, Ohmoto Y, Makino H.
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA, Movafagh BF, Reichlin M, Edmundson AB.
    J Mol Recognit; 1999 Feb; 12(5):249-57. PubMed ID: 10777254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S, Giudizi MG, Biagiotti R, Almerigogna F, Maggi E, Del Prete G, Ricci M.
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.